ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
16.95
-0.14 (-0.82%)
At close: Jul 8, 2025, 4:00 PM
16.88
-0.07 (-0.41%)
After-hours: Jul 8, 2025, 4:44 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.66 billion as of July 8, 2025. Its market cap has increased by 112.63% in one year.
Market Cap
1.66B
Enterprise Value
1.46B
1-Year Change
112.63%
Ranking
Category
Stock Price
$16.95
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.66B, an increase of 192.96%. That is a compound annual growth rate of 49.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 1.68B | 63.70% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |